DK0612522T3 - Blanding og fremgangsmåde til reduktion af risiko for hypotension - Google Patents

Blanding og fremgangsmåde til reduktion af risiko for hypotension

Info

Publication number
DK0612522T3
DK0612522T3 DK93117796T DK93117796T DK0612522T3 DK 0612522 T3 DK0612522 T3 DK 0612522T3 DK 93117796 T DK93117796 T DK 93117796T DK 93117796 T DK93117796 T DK 93117796T DK 0612522 T3 DK0612522 T3 DK 0612522T3
Authority
DK
Denmark
Prior art keywords
risk
hypotension
patient
composition
reducing
Prior art date
Application number
DK93117796T
Other languages
English (en)
Inventor
David A Mark
Gary Pace
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of DK0612522T3 publication Critical patent/DK0612522T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93117796T 1992-11-05 1993-11-03 Blanding og fremgangsmåde til reduktion af risiko for hypotension DK0612522T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/971,949 US5356873A (en) 1992-11-05 1992-11-05 Method for providing nutritional requirements to patients having a chronic inflammation reaction

Publications (1)

Publication Number Publication Date
DK0612522T3 true DK0612522T3 (da) 2001-08-13

Family

ID=25518983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93117796T DK0612522T3 (da) 1992-11-05 1993-11-03 Blanding og fremgangsmåde til reduktion af risiko for hypotension

Country Status (11)

Country Link
US (1) US5356873A (da)
EP (1) EP0612522B1 (da)
JP (1) JPH0797332A (da)
AT (1) ATE200734T1 (da)
AU (1) AU5040593A (da)
CA (1) CA2109392A1 (da)
DE (1) DE69330177T2 (da)
DK (1) DK0612522T3 (da)
ES (1) ES2157208T3 (da)
GR (1) GR3036272T3 (da)
PT (1) PT612522E (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US5378722A (en) * 1993-12-03 1995-01-03 Clintec Nutrition Co. Nutritional compositions for management of nitrogen metabolism
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
IL145894A0 (en) * 1999-04-29 2002-07-25 Novo Nordisk As Use of heparin-binding antagonists in the inhibition of bradykinin release
US6833350B2 (en) 2000-02-04 2004-12-21 Nestec S.A. Method for maintaining or improving the synthesis of mucins
JP2008506771A (ja) * 2004-07-19 2008-03-06 エヌ．ブイ．・ヌートリシア 血糖値を調節するためのアスパルテートを使用するための調製物
BRPI0710044A2 (pt) * 2006-04-04 2011-08-02 Nestec Sa tratamentos usando citrulina
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compositions for the treatment of liver disease
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4780475A (en) * 1986-02-03 1988-10-25 Cerra Frank B Preparation for the prevention of catabolism
US5055446A (en) * 1988-10-21 1991-10-08 University Of Cincinnati Method to improve survival of patients during sepsis by diet composition
US5158883A (en) * 1989-09-13 1992-10-27 Cornell Research Foundation, Inc. Method of using aminoarginine to block nitric oxide formation in vitro
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
EP0441119A3 (en) * 1990-01-09 1992-10-14 Richard D. Levere The use of l-arginine in the treatment of hypertension and other vascular disorders
CA2036770C (en) * 1990-02-26 2003-09-09 Jeffrey P. Whitten Inhibitors of nitric oxide biosynthesis
WO1993005780A1 (en) * 1991-09-27 1993-04-01 Board Of Regents, The University Of Texas System Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies

Also Published As

Publication number Publication date
AU5040593A (en) 1994-05-19
US5356873A (en) 1994-10-18
DE69330177D1 (de) 2001-05-31
CA2109392A1 (en) 1994-05-06
DE69330177T2 (de) 2001-09-06
ES2157208T3 (es) 2001-08-16
GR3036272T3 (en) 2001-10-31
PT612522E (pt) 2001-08-30
EP0612522B1 (en) 2001-04-25
JPH0797332A (ja) 1995-04-11
ATE200734T1 (de) 2001-05-15
EP0612522A1 (en) 1994-08-31

Similar Documents

Publication Publication Date Title
EP0222483A3 (en) Use of gamma-linolenic acid and related compounds in the treatment of endometriosis
NO951592L (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
NO945045L (no) Höykonsentrert immunglobulinpreparat og fremgangsmåte for dets fremstilling
AU6414994A (en) Composition and method for reducing toxicity of biologically-active factors
ATE330606T1 (de) Verfahren zur vorbeugung von nmda-rezeptor vermittelten neuronalen schäden
ZA909512B (en) Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
AU5763094A (en) Composition and method for treating patients with hepatic disease
DK0612522T3 (da) Blanding og fremgangsmåde til reduktion af risiko for hypotension
SE8803583L (sv) Farmaceutisk komposition
DK16389A (da) Anvendelse af en blanding til behandling af alopecia
MY106615A (en) Stabilized leukocyte-interferons.
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
GR3032156T3 (en) Treatment of human lactation failure.
ZA9410143B (en) Psoriasis treatment
DK0434989T3 (da) Fremgangsmåde til forbedring af ventilationen under søvn og til behandling af søvnrelaterede ventilationsabnormaliteter
DE3476736D1 (en) Use of an antihypoxidoticum with cerebral and peripheral effect
GR3004272T3 (da)
DK222988A (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
DE3767055D1 (de) N-(2,6-dichlor-m-tolyl)anthranilsaeure (mechlophenaminsaeure) enthaltenden gel-arzneiform zur verwendung in der lokaltherapie.
AU5199286A (en) New use of 1,4-dihydropyridine derivatives
TW217382B (da)
DE69734069D1 (de) Humanes wachstumshormon als hilfe gegen unterkühlung
UA30787A (uk) Спосіб лікування хронічного персистуючого гепатиту
UA15180A (uk) Спосіб коhсервативhого лікуваhhя геhералізоваhого пародоhтиту